Yayın:
Synthesis, Antidepressant-like and Anxiolytic-like Effects of Novel Thiadiazole Derivatives: Behavioral Assessment and Mechanistic Investigation

dc.contributor.authorÜmmühan Kandemir
dc.contributor.authorGizem Türkoğlu Sağlik
dc.contributor.authorDerya Osmaniye
dc.contributor.authorZafer Asım Kaplancıklı
dc.contributor.authorÖzgür Devrim Can
dc.contributor.authorÜmide Demir Özkay
dc.contributor.authorKandemir, Ümmühan
dc.contributor.authorOSMANİYE, DERYA
dc.contributor.authorKAPLANCIKLI, ZAFER ASIM
dc.contributor.authorCAN, ÖZGÜR DEVRİM
dc.contributor.authorDEMİR ÖZKAY, ÜMİDE
dc.date.accessioned2026-05-29T09:34:16Z
dc.date.issued2026-05-19
dc.description.abstractBackground/Objectives: Based on the central nervous system-related activity potential of 1,3,4-thiadiazole derivatives, novel 1,3,4-thiadiazole compounds were synthesized, and their possible antidepressant-like and anxiolytic-like effects were investigated. Methods: The chemical structures of the compounds were elucidated using several spectroscopic techniques. Antidepressant-like effects of compounds were evaluated using the tail suspension and the modified forced swimming tests, while anxiolytic-like effects were assessed using the hole board, elevated plus maze, and open field tests in male Balb/c mice. Motor activities of the animals were examined using the activity-meter device. Mechanistic and computational in silico studies were also performed. Results: The results demonstrated that compounds 4e–4i exhibited antidepressant-like effects, whereas only compound 4e showed an anxiolytic-like effect. None of the compounds produced significant alterations in motor activities of animals, indicating that the observed behavioral effects were specific. The antidepressant-like effects of compounds 4e–4i were abolished by p-chlorophenylalanine methyl ester (PCPA) and α-methyl-para-tyrosine methyl ester (AMPT) pre-administration indicating that the antidepressant-like effects of these test compounds are related to both serotonergic and catecholaminergic mechanisms. Furthermore, the anxiolytic-like effect of compound 4e was reversed by flumazenil and NAN-190 pre-administrations, indicating the participation of the GABA-A benzodiazepine receptor complex and 5-HT1A receptors in its pharmacological activity. Computational in silico studies revealed that compounds have good ADME profiles; compounds 4e–4i interact with the serotonin transporter; compound 4e shows affinity for GABA-A and 5-HT1A receptors; and all interactions remain stable under dynamic conditions. Conclusions: These findings supported the previous papers reporting the antidepressant-like and anxiolytic-like effects of 1,3,4-thiadiazole derivatives.en
dc.description.urihttps://doi.org/10.3390/ph19050797
dc.identifier.doi10.3390/ph19050797
dc.identifier.endpage797
dc.identifier.issn1424-8247
dc.identifier.openalexW7162263680
dc.identifier.pubmed42198471
dc.identifier.startpage797
dc.identifier.urihttps://hdl.handle.net/11421/40171
dc.identifier.volume19
dc.publisherMultidisciplinary Digital Publishing Institute
dc.relation.ispartofPharmaceuticals
dc.subjectSerotonergic
dc.subjectIn silico
dc.subjectADME
dc.subjectFlumazenil
dc.subjectOpen field
dc.subjectCatecholaminergic
dc.subjectAntagonist
dc.subjectTail suspension test
dc.subjectBehavioural despair test
dc.titleSynthesis, Antidepressant-like and Anxiolytic-like Effects of Novel Thiadiazole Derivatives: Behavioral Assessment and Mechanistic Investigation
dc.typearticle
dspace.entity.typePublication

Dosyalar

Koleksiyonlar